Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
212 EUR | 0.00% |
|
+3.16% | -3.85% |
Jul. 10 | Health Care Up in Anticipation of Deal Activity -- Health Care Roundup | DJ |
Jul. 10 | FDA Reports Supply Interruptions for Becton Dickinson BD BACTEC Culture Media Bottles | DJ |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 32.37 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 3.94 times its current sales, is high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.85% | 66.67B | - | ||
-6.68% | 179B | C+ | ||
-5.20% | 100B | C | ||
+18.16% | 44.81B | B+ | ||
-6.47% | 46.16B | B- | ||
+9.74% | 44.38B | B- | ||
+14.01% | 29.53B | B | ||
+22.31% | 25.83B | A- | ||
-6.53% | 23.97B | A- | ||
-11.70% | 22.11B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BDX Stock
- BOX Stock
- Ratings Becton, Dickinson and Company